Analysed DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) News Sources
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06-04-2026
yahoo.com
How Investors May Respond To Dianthus Therapeutics (DNTH) Early “GO” Decision And FDA Backing For Claseprubart
03-04-2026
yahoo.com
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?
01-04-2026
yahoo.com
Wedbush Keeps Outperform on Dianthus Therapeutics, Inc. (DNTH), Highlights Potential of Claseprubart in CIDP
18-03-2026
yahoo.com
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
18-03-2026
fool.com
Dianthus Therapeutics Hits Early “Go” in CAPTIVATE Phase 3 CIDP Trial, Drops 600 mg Arm
15-03-2026
marketbeat.com
Dianthus Therapeutics (DNTH) Is Up 30.8% After Upsized Raise And Early Phase 3 “Go” Decision
13-03-2026
yahoo.com
What is the current price of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)?
The current price of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) is $90.15.
DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) absolute price change since previous trading day?
The absolute price change of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) since the previous trading day is $-1.77.
DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) percentage price change since previous trading day?
The percentage price change of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) since the previous trading day is -1.9256%.
What is the most recent average sentiment score for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)?
The most recent average sentiment score for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)?
The most recent sentiment for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) is .
SEC-8K** Filing Available For DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.